Abstract
MRgFUS represents a promising alternative for patients with. chronic neuropathic that have failed medical management and other treatment options. Early single center experience with chronic neuropathic pain and Trigeminal Neuralgia has demonstrated favorable long-term outcomes. Excellent safety profile with low risk of motor and sensory complications and so far anecdotal permanent neurological deficits make FUS a powerful tool to treat patients that are otherwise hopeless. Neuromodulation may be the most influential factor driving outcomes and studies devised to detect neuroplasticity will be critical to guide such therapies. Future studies should focus on investigating other potential targets, such as the cingulate gyrus or the mesencephalon, as well as integrating control populations in trials.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Magnetic Resonance Imaging Clinics of North America
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
